Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AromaStick AG is a Swiss healthcare company that develops and manufactures specialized nasal inhalers designed to improve well-being through scent-based physiological triggers. The company's products utilize patented delivery technology to provide highly concentrated organic essential oil blends directly to the olfactory system, bypassing the dilution common in room diffusers. AromaStick emphasizes a research-driven approach, with several published clinical studies investigating the effects of their inhalers on blood pressure, heart rate, and cortisol levels. Their commercial portfolio includes targeted formulations for stress management, cognitive enhancement, and athletic performance. Headquartered in Sargans, Switzerland, the company distributes its products globally to consumers seeking non-pharmacological wellness solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AromaStick.